Pol Treg Appoints Dan Shelly As Chief Business Development Officer

Feb 21, 2024•over 1 year ago

Position

Chief Business Development Officer

Company

PolTREG S.A

Dan Shelly

GdańskBiotechnology Research

Description

PolTREG S.A. appoints Prof. Daniel Shelly, PhD, MBA as Chief Business Development Officer.

Company Information

Company

PolTREG S.A

Location

Gdańsk, Pomeranian Voivodeship, Poland

About

PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. PolTREG is the most advanced company in TREGS cellular therapies worldwide, breakthrough therapies for type 1 diabetes (T1D) and multiple sclerosis (MS). PolTREG has very promising results regarding the safety and efficacy of TREGS therapy (completed phase I/II clinical trials in T1D and phase I in MS), ready for the next phase of trials. The company is after EMA Scientific Advice procedure.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months